North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

The stock's fall snapped a two-day winning streak.

ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

Abbott Labs is the company behind consumer nutrition brands like Ensure and Pedialyte, according to its product page, but its portfolio is diversified beyond that and touching multiple clinical ...

Abbott Laboratories is a global healthcare leader with a rich history of over 130 years. The company operates in over 160 countries worldwide and develops products and technologies to enhance ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by Evercore ISI to $136.00 in a report released on Thursday morning,Stock Target Advisor reports. They currently have a buy ...

International Assets Investment Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 99.1% during the 4th quarter, Holdings Channel reports. The fund owned 14,721 shares ...

Abbott Labs has recently completed its ambitious plan to roll out what the firm refers to as the "Fab Five" products. This lineup, which includes the newly launched TriClip, alongside existing ...

In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...